Tachykinins belong to a family of neuropeptides that share a common C-terminal sequence Phe-Xaa-Gly-Leu-Met-NH 2 that is crucial for interaction with their receptors (Severini et al., 2002; Pennefather et al., 2004) . The mammalian tachykinins include substance P (SP), neurokinin (NK) A and NKB, the effects of which are mediated by the receptors NK 1 , NK 2 and NK 3 . SP is the most potent tachykinin at the NK 1 receptor site, whereas NKA exhibits the highest affinity for the NK 2 receptor and NKB for the NK 3 receptor (Pennefather et al., 2004) . The effects through NK receptors are generally coupled to a G protein (G q /G 11 ) regulated phosphoinositide pathway (Khawaja and Rogers, 1996) , but G protein-independent coupling has also been described (Yang et al., 2003) .
NK receptors are implicated in various biological effects that include smooth muscle contraction, inflammatory processes, hypotensive effects and stimulation of gland secretion (Severini et al., 2002) . In the nervous system, tachykinins also operate as neuromodulators/neurotransmitters via mechanisms that are generally excitatory (Stacey et al., 2002) . In addition, there is evidence that tachykinins also have intrinsic neuroprotective properties. They were found to reverse β-amyloid-induced toxicity (Kowall et al., 1991) , to protect against excitotoxic cell death (Calvo et al., 1996) and to limit neurodegeneration caused by trophic factor deprivation (Lallemend et al., 2003) .
The loss of nigrostriatal dopaminergic (DA) neurons in Parkinson disease and related disorders leads to profound motor impairment (Agid, 1991) . The identification of signals or factors that control the survival and function of DA neurons is therefore of interest as it might not only provide a better understanding of the pathophysiological mechanisms of these diseases, but also foster the development of new therapeutical strategies to halt their progression (Dawson and Dawson, 2002) . There is indirect evidence that tachykinins may influence the survival of mesencephalic DA neurons; (1) in the brain, the substantia nigra is the richest area in SP and SP-containing axon terminals (Hokfelt et al., 1991) ; (2) (Mauborgne et al., 1983; Betarbet and Greenamyre, 2004) ; (3) excitatory stimuli, which are believed to play a key role in the survival of DA neurons during development and possibly in the adult brain (Douhou et al., 2001; Katsuki et al., 2001; Salthun-Lassalle et al., 2004) , can be evoked by direct application of NK 1 or NK 3 agonists to mesencephalic DA neurons (Nalivaiko et al., 1997) .
To examine the potential of tachykinins to promote the survival of DA neurons, we have used a model system in which these neurons die spontaneously and progressively as a function of time (Michel and Agid, 1996) . More specifically, we wished to: 1) evaluate the neuroprotective potential of native and synthetic tachykinins for DA neurons; 2) determine what receptor subtypes are involved; 3) establish whether these mechanisms are shared with or related to that of GDNF, a prototypical neuroprotective factor for DA neurons (ChoiLundberg et al., 1997) ; 4) explore the mechanisms underlying neuroprotection.
This article has not been copyedited and formatted. The final version may differ from this version. Others pharmacological reagents were from Sigma-RBI-Aldrich. Tritiated neurotransmitters and tritiated methyl-thymidine were from Amersham Biosciences (Orsay, France).
Mesencephalic cell cultures
Animals were treated in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council 1996) , the European Directive N°86/609, and the guidelines of the local institutional animal care and use committee. Cultures were prepared from the ventral mesencephalon of embryonic day 15.5 Wistar rat embryos (Janvier Breeding Center, Le Genest St Isle, France) as described previously (Michel and Agid, 1996) .
After dissection, pieces of mesencephalic tissue were dissociated mechanically with no enzymatic treatment using a Gilson Pipetman set to 900µl, and plated onto polyethylenimine (1mg/mL; Sigma-Aldrich, St Quentin Fallavier, France)-coated 24-well culture plates. Cells plated at a density of 1.5-2.0x10 5 /cm 2 were then maintained at 37°C in a humidified incubator with a 5% CO 2 atmosphere using 500µL of N5 culture medium (Salthun-Lassalle et al., 2004) supplemented with 5mM glucose, 5% horse serum and 0.5% fetal bovine serum, except for the first 3 days when 2.5% fetal bovine serum was used to enhance cell attachment.
The cultures were fed daily by replacing 350µl of the culture medium. They were then supplemented with appropriate pharmacological treatments including native tachykinins and agonists/antagonists of tachykinin receptors.
Quantification of neuronal survival
The survival of DA neurons was quantified by counting the number of cells labeled with an antibody against tyrosine hydroxylase (TH), as previously described. Briefly, the cultures were fixed with 4% formaldehyde in phosphate-buffered saline (PBS) for 15 min.
Cells were washed three times with PBS and then incubated 24 hours at 4°C with a monoclonal anti-TH antibody (Diasorin, Stillwater, Min, USA) diluted 1:5000 in PBS containing 0.2% Triton X-100. The TH antibody was then revealed with an anti-mouse IgG Cy3 conjugate (1:500; Sigma-RBI-Aldrich) for 2 hours at room temperature. Mesencephalic cultures contained between 1-2% TH + cells at the time of plating. All neurons, regardless of their neurotransmitter phenotype, were identified by labeling microtubule-associated protein-2 (MAP2) with a monoclonal antibody (AP-20, Sigma) diluted 1:100 in PBS revealed with a anti-mouse Alexa Fluor 488 conjugate.
Measurement of neurotransmitter uptake
The functional integrity of DA neurons was evaluated by their ability to take up dopamine (DA) by active transport (Douhou et al., 2001 (Troadec et al., 2002) . In this case, the incubation time was prolonged This article has not been copyedited and formatted. The final version may differ from this version. 
Quantification and identification of proliferating cells
[ 3 H]-methyl-thymidine, a marker of DNA synthesis, was used to label and quantify proliferating cells as described (Mourlevat et al., 2003) . Mesencephalic cultures maintained up to 7 DIV in the presence of test treatments were exposed to 1µCi [ 3 H]-methyl-thymidine (Amersham Biosciences; 40Ci/mmol) for 3h at 37°C in serum-free N5 medium supplemented with 5mM glucose. After three rapid washes, the cells were allowed to recover for 1h in the same culture medium to remove unincorporated radioactivity. The cultures were fixed in 4% formaldehyde for 15 min and when necessary processed for TH immunofluorescence detection subsequently. They were then dehydrated in ethanol and exposed to Hypercoat LM-1 emulsion (Amersham Biosciences) for 4 days at 4°C to detect the tritiated label.
Quantification of intracellular calcium levels
Cytoplasmic-free calcium levels were measured in individual neurons using Calcium
Green-1-AM (Molecular Probes, Eugene, OR) as described previously (Douhou et al., 2001; Salthun-Lassalle et al., 2004) .
This article has not been copyedited and formatted. The final version may differ from this version. (Pinto et al., 1999) . The PCR products were visualized by electrophoresis in a 2% agarose gel containing 0.1mg/mL ethidium bromide.
Statistical analysis
Simple comparisons between two groups were performed with Student's t-test.
Multiple comparisons against a single reference group were made by one-way analysis of variance (ANOVA) followed by Dunnett's test. When all pairwise comparisons were made, the Student-Newman-Keuls test was used. SEM values were derived from at least three independent experiments.
This article has not been copyedited and formatted. The final version may differ from this version. The native tachykinins SP, NKA and NKB increased the number of TH + DA neurons in mesencephalic cultures (Fig. 1A-C, E) . The effects of SP and NKB on the number of TH + cells were restricted to a narrow range of concentrations between 1-50nM and 1-5nM, respectively, with peak effects at 10nM and 1nM (Fig. 1A, C) . At higher concentrations, no effect of SP or NKB on the number of DA neurons was observed. NKA treatment increased the number of DA cells as well, but at much higher concentrations (100-1000nM; Fig. 1B , E).
Synthetic peptide agonists of NK 1 and NK 3 but not NK 2 receptors mimic the effects of native tachykinins
SP, NKA and NKB are believed to act preferentially through NK 1 , NK 2 and NK 3 receptors, respectively (Pennefather et al., 2004) . To determine whether selective agonists of these receptors could reproduce the effects of native tachykinins on DA neurons, we treated mesencephalic cultures with the NK 1 agonist GR73632, the NK 2 agonist GR64349 and the NK 3 agonist [pro7]-NKB. Consistent with the results obtained with SP and NKB, the number of DA neurons increased in the presence of GR73632 and [pro7]-NKB ( Fig. 1D) , in a narrow range of concentrations. The peak effect was estimated at 10nM for GR73632 and 1nM for
[pro7]-NKB (Fig. 1D) . Unexpectedly, however, the NK 2 receptor agonist GR64349 did not affect the number of TH + cells, indicating that the action of NKA was probably mediated by its non-preferential receptors.
This article has not been copyedited and formatted. The final version may differ from this version. receptors, i.e., GR71251, R396 and SB218795 respectively, were added (all at 1µM) to mesencephalic cultures in the presence of the NK 1 receptor agonist GR73632 or the NK 3 receptor agonist [pro7]-NKB ( Fig. 2A ). As expected, the NK 1 receptor antagonist GR71251
prevented GR73632-mediated increase in DA cells whereas the NK 2 antagonist R396 and the NK 3 antagonist SB218795 did not ( Fig. 2A) . Similarly, the effect of the selective NK 3 agonist
[pro7]-NKB on DA neurons was abolished by the corresponding antagonist SB218795, but not by the antagonists of NK 1 or NK 2 receptors ( Fig. 2A) . Note that the number of DA neurons was not further increased when we combined the NK 1 and NK 3 agonists at optimal concentrations ( Fig. 2A ).
We then intended to determine what receptor mediated the effects of native tachykinins ( Fig. 2B-D) . The NK 1 antagonist GR71251 was sufficient in itself to suppress the effect of SP, indicating that this tachykinin increased the number of DA neurons only through its preferential receptor (Fig. 2B) . Surprisingly, however, both NK 3 and NK 1 antagonists were required to completely suppress the effect of NKB. Separately, each of these antagonists had only partial effects (Fig. 2D ). This indicates that the effect of NKB was mediated by the concomitant activation of NK 1 and NK 3 receptors. The effects of NKA that acts preferentially through NK 2 receptors, were resistant to the selective NK 2 receptor antagonist R396 ( Fig.   2C ), suggesting the probable involvement of non-preferential NK receptors. Accordingly, the effect of NKA was prevented by a treatment combining NK 1 and NK 3 receptor antagonists.
Consistent with these different results, mRNA transcripts for NK 1 and NK 3 receptors were detected in mesencephalic cultures using RT-PCR amplification ( Fig. 2E ) whereas mRNA This article has not been copyedited and formatted. The final version may differ from this version. transcripts for NK 2 receptors were not. Note that all three receptors were amplified from rat uterus mRNA used as a positive control (Pinto et al., 1999 From previous studies, we know that this culture model is characterized by a spontaneous and progressive loss of DA neurons (Michel and Agid, 1996; Salthun-Lassalle et al., 2004) . Accordingly, we found that ~50% of TH + neurons had disappeared by 5 DIV and more than 70% at 10 DIV (Fig. 3A) . We demonstrate, here, that the pancaspase inhibitor Boc-D-fluoromethylketone (Boc-D-FMK) prevented DA cell loss efficiently (Fig. 3A) , which confirms indirectly that a slowly occurring apoptotic process was affecting these neurons (Michel and Agid, 1996; Salthun-Lassalle et al., 2004 (Fig. 5B) . In contrast, the agonist of voltagegated Na + channels, veratridine, which also provided robust neuroprotection to DA neurons in this model system (Salthun-Lassalle et al., 2004) , had no effect on the accumulation rate of DA by these neurons (Figs. 5B and 6 ). Note the virtual absence of cells accumulating [ 3 H]-DA in cultures treated with the inhibitor of the DA transporter GBR-12909 (0.5µM) prior to the uptake (Fig. 6 ). (Fig. 8) .
The rescue of DA neurons caused by activation of NK receptors does not depend upon the secretion of a trophic factor
We wished to determine whether the effect mediated by NK 1 and NK 3 receptors was possibly mediated by GDNF, a prototypical trophic factor for DA neurons. Therefore, we tested the effects of GR73632 (10nM) and [pro7]-NKB (1nM) in the presence of an anti-GDNF antibody (AB 212-NA; 5 µg/ml) that neutralizes the biological activity of the trophic peptide (Fig. 9A) . Whereas the antibody blocked the increase in DA cell survival produced by GDNF (10ng/mL), it had no effect on neuronal survival promoted by tachykinins. This indicates that the effect of tachykinins was not dependent upon the secretion of GDNF in the culture medium.
To exclude the effect of another putative factor secreted by glial or neuronal cells, we assessed the survival of TH + cells maintained in a culture medium that had been conditioned previously by mesencephalic cultures exposed continuously to GR73632 (10nM) or [pro7]-NKB (1nM). The two conditioned media protected the DA neurons but only because they contained GR73632 or [pro7]-NKB, the effects of which were blocked by the corresponding NK 1 and NK 3 receptor antagonists, GR71251 and SB218795 (Fig. 9B ).
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Neuroprotection of DA neurons by tachykinins: role of voltage-gated ionic channels
We have shown previously that voltage-gated ionic channels are crucially involved in the survival of DA neurons in this model system (Douhou et al., 2001; Salthun-Lassalle et al., 2004) . In particular, we showed that DA neurons can be rescued from death by low-level activation of voltage-gated Na + channels using the alkaloid veratridine (Salthun-Lassalle et al., 2004) , the effect of which were blocked by the Na + channel antagonist TTX. The effects of the agonists of NK 1 (GR73632) and NK 3 ([pro7]-NKB) receptors on DA neurons were prevented by TTX (100nM) indicating that Na + channels were also implicated in the effects of tachykinins (Fig. 10A, C) . This finding and the fact that suboptimal amounts of veratridine (0.2µM) were able to improve the protective effect of optimal concentrations of [pro7]-NKB ( Fig. 10A ) and GR73632 (not shown) suggested that the alkaloid and tachykinins promoted DA cell survival by a mechanism that was common. This was apparently not the case since the T-type calcium channel blocker flunarizine (5µM), which prevented the survival promoting effect of the alkaloid (Salthun-Lassalle et al., 2004), was unable to inhibit the effects of [pro7]-NKB or GR73632 (Fig. 10B) . The neuroprotective effects of GR73632 and
[pro7]-NKB were also resistant to nimodipine (10µM), an inhibitor of the L-type calcium channels. They were reduced, however, by the snail toxin ω-conotoxin MVIIA (0.5µM; Fig.   10B , C), indicating that inward calcium currents through N-type calcium channels played probably a key role in the survival of DA neurons mediated by NK 1 and NK 3 receptors. As expected, the protective effects of native tachykinins, SP and NKB, were also blocked by treatment with TTX and ω-conotoxin MVIIA (Fig. 10A-B) . Interestingly, the rescuing effect of veratridine, which was prevented by TTX, remained unaffected by ω-conotoxin MVIIA (Fig. 10B) , confirming that the veratridine and tachykinins acted by mechanisms, which were partly related but not identical.
This article has not been copyedited and formatted. The final version may differ from this version. To confirm that tachykinin-mediated neuroprotection was linked to activation of inward Ca 2+ currents, we measured intracellular calcium levels in the presence of the various test treatments (Fig. 10D) . At concentrations of NK 1 and NK 3 agonists that promote optimal survival of DA neurons, we observed an increase in [Ca 2+ ] i of ~60-80% above control levels.
The capacity of tachykinins to raise [Ca 2+ ] i was abolished by TTX (0.1µM) or ω-conotoxin MVIIA (0.5µM) which indicates that voltage-gated Na + channels and N-type calcium channels played a key role in this effect (Fig. 10D) . Unlike ω-conotoxin MVIIA, however, the L-type calcium channel antagonist nimodipine (10µM) and the T-type calcium channel antagonist flunarizine (5µM) failed to reduce the rise in [Ca 2+ ] i induced by tachykinins (data not shown). Note that veratridine-mediated increase in intracellular calcium was blocked by TTX as expected but not by ω-conotoxin MVIIA (Fig. 10D ).
Discussion
We demonstrate here that stimulation of NK 1 and NK 3 but not NK 2 receptors by native tachykinins or synthetic peptide agonists provides robust and selective neuroprotection against DA cell death in mesencephalic cultures. Neuroprotection was mimicked by, but independent of GDNF. It resulted from a depolarizing effect mediated through the activation of TTX-sensitive sodium channels and N-type voltage-gated calcium channels.
This article has not been copyedited and formatted. The final version may differ from this version. (Rothman et al., 1980 The effect of the tachykinin agonists might be simply to restore the expression of TH within neurons that contain undetectable amounts of the enzyme as they entered a pre-morbid state (Hirsch et al., 1988; Michel and Agid, 1996) . Even though tachykinins were reported to stimulate TH protein expression (Friedman et al., 1988) , this possibility is doubtful since the tachykinin agonists failed to rescue the fraction of TH + neurons that had already disappeared when initiation of the treatments was delayed. The observation that the pancaspase inhibitor BOC-D-FMK was also able to increase the number of DA neurons in this model system indicates that the tachykinins probably reversed an ongoing apoptotic process that is occurring spontaneously (Salthun-Lassalle et al., 2004) . The underlying mechanism was, however, not related to that described for the neurotransmitter adenosine and certain antimitotics, which were effective in this culture model through the repression of glial cell proliferation (Michel et al., 1999) . Finally, it is worth noting that DA neurons treated with NK 1 and NK 3 receptor agonists efficiently accumulated DA by active transport, which indicates that these neurons were perfectly functional when protected by tachykinins.
TTX-sensitive sodium channels and N-type voltage-gated calcium channels are implicated in tachykinin-mediated neuroprotection
Two observations indicate that inward sodium currents were critical for tachykininmediated neuroprotection. The effect of NK 1 and NK 3 receptor agonists was mimicked by veratridine, an agonist of the voltage-gated Na + channels (Salthun-Lassalle et al., 2004 ) and prevented by TTX, an irreversible antagonist of these channels (Catterall, 1980 excitatory responses in DA neurons of the substantia nigra (Nalivaiko et al., 1997) . We have previously established that low-level activation of voltage-gated Na + channels by the alkaloid veratridine protects DA neurons via a mechanism that requires calcium influx through lowthreshold activated T-type calcium channels (Salthun-Lassalle et al., 2004) . T-type calcium channels are reported to be activated in response to SP in certain types of neurons (Ikeda et al., 2003) . In our study, however, the effects of the tachykinin agonists were resistant to flunarizine, an inhibitor of these channels (Santi et al., 2002) . High-threshold activated L-and N-type calcium channels which have been shown to contribute to the effects of tachykinins in several model systems (Bayguinov et al., 2003; Sculptoreanu and de Groat, 2003) might also participate to tachykinin-mediated neuroprotection in mesencephalic cultures. L-type calcium currents are implicated in the rescue of mesencephalic DA neurons by depolarizing concentrations of K + (Douhou et al., 2001 ) but a selective antagonist of these channels nimodipine failed to inhibit the action of tachykinins on these neurons. In contrast, N-type calcium channels were probably essential for the survival promoting effect of tachykinins.
Indeed, blockade of these channels by the snail toxin ω-conotoxin MVIIA (Hirata et al., 1997) abolished neuroprotection by tachykinins. Consistent with this observation, the moderate rise in [Ca 2+ ] i elicited by tachykinins was also reversed by ω-conotoxin MVIIA. This elevation was also prevented by blocking Na + channels with TTX, which provides further support to the idea that intracellular calcium levels were crucially involved in the survival of these neurons.
Finally, the efficacy of TTX to prevent the rise in calcium produced by tachykinins is an indication that Na + inward currents may precede the activation of N-type Ca 2+ channels.
The present results demonstrate that N-type calcium channels possess in common with L-, and T-type calcium channels (Douhou et al., 2001; Salthun-Lassalle et al., 2004) , the ability to modulate DA cell survival. These channels have different voltage ranges as well as This article has not been copyedited and formatted. The final version may differ from this version. rates of activation and inactivation (Hammond, 2001 ) which probably explains why their recruitment depends largely upon the nature and intensity of the excitatory stimuli applied on DA neurons. Overall, the crucial need of DA neurons for electrical stimulation suggests (1) that they lack adequate excitatory inputs in culture and (2) that tachykinins could act as substitutes. It is interesting to note that only DA neurons in this model system appear dependent on such input. Finally, the rapid reversal of the effects of NK 1 and NK 3 receptor agonists when they are withdrawn indicates that tachykinin-dependent excitatory signals were a permanent requirement for long-term survival of DA neurons.
Is there a link between the survival promotion mediated by tachykinins and GDNF?
We wished to determine whether NK 1 and NK 3 receptor agonists could operate through a mechanism involving GDNF, a major neurotrophic factor for DA neurons (ChoiLundberg et al., 1997) . This was excluded since a neutralizing antibody that prevented the rescue of DA neurons by GDNF did not interfere with the effects of the NK 1 or NK 3 receptor agonists. Other autocrine or paracrine trophic factors were probably not implicated either, as shown by our experiments with conditioned media. These experiments support the idea that tachykinins and synthetic peptide agonists acted directly on DA neurons which express both NK 1 (Futami et al., 1998) and NK 3 receptors (Chen et al., 1998; Friedman et al., 2002) . A doubt subsists, however since the presence of NK 1 receptors on DA neurons is still a question of debate (Futami et al., 1998) and the experiments using conditioned culture media might have failed to detect molecules having a short-range diffusion or a limited lifespan. Finally, GDNF being known to stimulate the synthesis of substance P (Ogun-Muyiwa et al., 1999) , in particular in the striatum (Humpel et al., 1996) , we envisaged the possibility that some of its effects might be mediated by tachykinins. This was unlikely since TTX which prevented the rescuing effect of tachykinins on DA neurons failed to reduce that of GDNF on the same This article has not been copyedited and formatted. The final version may differ from this version. (Oo et al., 2003) . Because GDNF is still effective when applied exogenously to injured DA neurons in the adult brain (Choi-Lundberg et al., 1997; Dauer and Przedborski, 2003) , it is reasonable to ask whether tachykinins could be neuroprotective in neurodegenerative conditions where DA neurons die selectively such as
Parkinson's disease and related disorders.
